These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2123958)

  • 1. Gadolinium(III) complex equilibria: the implications for Gd(III) MRI contrast agents.
    Jackson GE; Wynchank S; Woudenberg M
    Magn Reson Med; 1990 Oct; 16(1):57-66. PubMed ID: 2123958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity.
    Parac-Vogt TN; Vander Elst L; Kimpe K; Laurent S; Burtéa C; Chen F; Van Deun R; Ni Y; Muller RN; Binnemans K
    Contrast Media Mol Imaging; 2006; 1(6):267-78. PubMed ID: 17191767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
    Puttagunta NR; Gibby WA; Puttagunta VL
    Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of equilibrium and kinetic properties in the dissociation of Gd[DTPA-bis(methylamide)] (Omniscan) at near to physiological conditions.
    Baranyai Z; Brücher E; Uggeri F; Maiocchi A; Tóth I; Andrási M; Gáspár A; Zékány L; Aime S
    Chemistry; 2015 Mar; 21(12):4789-99. PubMed ID: 25678406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal ion speciation in blood plasma: gallium-67-citrate and MRI contrast agents.
    Jackson GE; Byrne MJ
    J Nucl Med; 1996 Feb; 37(2):379-86. PubMed ID: 8667080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speciation of Gd-based MRI contrast agents and potential products of transmetalation with iron ions or parenteral iron supplements.
    Telgmann L; Wehe CA; Künnemeyer J; Bülter AC; Sperling M; Karst U
    Anal Bioanal Chem; 2012 Nov; 404(8):2133-41. PubMed ID: 23001305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solvate structures in water-methanol solutions of MRI contrast agents: electron spin echo envelope modulation in gadolinium chelates.
    Clarkson RB; Hwang JH; Belford RL
    Magn Reson Med; 1993 Apr; 29(4):521-7. PubMed ID: 8385260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S; Ruloff R; Tóth E; Merbach AE
    Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation kinetics of open-chain and macrocyclic gadolinium(III)-aminopolycarboxylate complexes related to magnetic resonance imaging: catalytic effect of endogenous ligands.
    Baranyai Z; Pálinkás Z; Uggeri F; Maiocchi A; Aime S; Brücher E
    Chemistry; 2012 Dec; 18(51):16426-35. PubMed ID: 23139193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between thermodynamics and the toxicity of gadolinium complexes.
    Cacheris WP; Quay SC; Rocklage SM
    Magn Reson Imaging; 1990; 8(4):467-81. PubMed ID: 2118207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of gadolinium complexes on different enzyme systems.
    Allard M; Caillé JM; Bonnemain B; Meyer D; Simonnet G
    Acta Radiol Suppl; 1986; 369():572-4. PubMed ID: 2980561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of DTPA analogues derived from piperidine and azepane: potential contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Brechbiel MW
    J Org Chem; 2001 Nov; 66(23):7745-50. PubMed ID: 11701031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors.
    Larsson HB; Stubgaard M; Frederiksen JL; Jensen M; Henriksen O; Paulson OB
    Magn Reson Med; 1990 Oct; 16(1):117-31. PubMed ID: 2255233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Fe(III)-deferoxamine and Mn(II)-pectin as magnetic resonance imaging contrast agents.
    Mino Y; Kitagaki H; Sasaki M; Ishii K; Mori T; Yamada K; Nagasawa O
    Biol Pharm Bull; 1998 Dec; 21(12):1385-8. PubMed ID: 9881662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging.
    Laurent S; Vander Elst L; Galaup C; Leygue N; Boutry S; Picard C; Muller RN
    Contrast Media Mol Imaging; 2014; 9(4):300-12. PubMed ID: 24706614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning--a comparison of methods.
    Larsson HB; Tofts PS
    Magn Reson Med; 1992 Mar; 24(1):174-6. PubMed ID: 1556924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
    Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
    Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal chelates as urographic contrast agents for magnetic resonance imaging. A comparative study.
    Marotti M; Schmiedl U; White D; Ramos E; Johnson T; Engelstad B
    Rofo; 1987 Jan; 146(1):89-93. PubMed ID: 3027795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
    Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.